North America SGLT2 Inhibitors Market: Emerging Trends in Diabetes Management
Polaris Market Research today announced findings from its latest report, projecting the North America SGLT2 Inhibitors Market to grow from USD 7.32 billion in 2024 to USD 16.37 billion by 2034, at a CAGR of 8.4% during 2025–2034. The report profiles 10 leading companies across four segmentation categories: indication, drug, distribution channel, and country. Rising obesity, type 2...
0 Commentarii 0 Distribuiri 3 Views 0 previzualizare